Spyre Therapeutics
SYRE | NASDAQ
$99.37
-$4.63 (-4.45%)
At close: Nov 16, 2026, 4:00 PM ET
$99.37
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Spyre Therapeutics Statistics
Key statistics explainedMarket Data
$9.44B
$8.37B
3.23
1.25M
88.41M
46.34%
N/A
NASDAQ
US00773J2024
Price Performance
24.4%
-5.0%
41.8%
203.3%
307.9%
869.5%
-41.4%
24.4%
322.8%
-9.6%
-3.3%
Valuation
-36.27
N/A
0.47
-0.75
104.28
56,622.40
8.97
-37.85
-31.50
-35.24
92.44
-30.93
-30.93
-33.55
-2.8%
-2.6%
-3.2%
Financial Health
$1.07B
$0
$1.07B
$1.1B
27.40
27.40
0.00
-0.00
-0.00
N/A
0.00
121.70
4
Margins & Profitability
50.0%
-276.4%
-298.9%
-291.6%
-275.5%
-331.1%
55.6%
-20.2%
Returns
-24.0%
-29.8%
-23.6%
-23.6%
-24.0%
Historical Growth (CAGR)
341.2%
43.1%
33.7%
53.3%
56.1%
15.6%
-26.2%
-28.1%
-21.5%
Analyst Forecasts
Buy
13
-28.0%
-14.1%
Feb 18, 2027
-$1.01
44.7%
N/A
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$120.50
21.3%
Cash Flow
$-249.32M
$-249.32M
$-299.62M
-$2.82
-$2.82
-275.5%
Income Statement
$90.49M
$45.25M
$-250.17M
$-270.49M
$-263.86M
-$2.74
$723.95K
$-2.11M
125
Add to Watchlist
Select watchlists to add or remove SYRE